Rongtong Dictionary · Formula

Xiao Chaihu Decoction: Origins, the Logic of Harmonizing Shaoyang, the Bupleurum-Formula Lineage, and Modern Pharmacology

Published and reviewed 2026-07-09

Xiao Chaihu (Minor Bupleurum) Decoction is the representative 'harmonize shaoyang' formula of Zhang Zhongjing's Shanghan Zabing Lun and the base type of the entire bupleurum-formula family, built from bupleurum, scutellaria, pinellia, fresh ginger, ginseng, jujube, and honey-fried licorice into a cold-warm, tonify-and-drain structure for the shaoyang pattern of alternating chills and fever, chest-and-flank fullness, poor appetite, and irritability with retching. It is both a model for the 'harmonizing method' and, because its Japanese Kampo preparation (TJ-9) was linked to interstitial pneumonia and liver injury, a textbook case of why formula, preparation, and population must each be checked separately.

Origin: the base type of the bupleurum formulas

Xiao Chaihu Decoction appears in Zhang Zhongjing's Shanghan Zabing Lun (c. 200 CE, later split into the Shanghan Lun and the Jinkui Yaolue) as the core formula of the shaoyang chapter and the base type of every later 'bupleurum formula.' Pharmacy scholarship counts more than twenty passages referencing it, spread across the taiyang, yangming, shaoyang, jueyin, and convalescence chapters — a measure of how broadly Zhongjing deployed it.

The governing passage (Shanghan Lun §96) prescribes it for a patient five or six days into an illness with alternating chills and fever, chest-and-flank fullness, silent reluctance to eat, and irritability with retching, followed by a string of optional signs. More famous still is §101: when a bupleurum pattern is present, 'the appearance of a single sign is enough — they need not all be present.' This 'a single sign is enough' became the classical basis for the flexible use of the formula and for the wider diagnostic habit of 'seizing the chief sign.' The classical text also specifies an unusual method — decoct, remove the dregs, then re-decoct. This page identifies the entity only and offers no dose conversion or preparation procedure.

Composition: a harmonizing structure built on bupleurum and scutellaria

Seven ingredients: bupleurum (Bupleuri Radix, sovereign), scutellaria (Scutellariae Radix, minister), pinellia (Pinelliae Rhizoma), fresh ginger (Zingiberis Rhizoma Recens), ginseng (Ginseng Radix), jujube (Jujubae Fructus), and honey-fried licorice (Glycyrrhizae Radix). The bupleurum-scutellaria pairing is the core of every bupleurum formula.

In the textbook reading, bupleurum — bitter and neutral, entering the liver and gallbladder — is the shaoyang specific: it both vents the half-exterior pathogen outward and courses stagnant qi dynamic, serving as sovereign; scutellaria, bitter and cold, clears the half-interior heat, serving as minister. The pair, one venting and one clearing, forms the skeleton of 'harmonizing shaoyang.' Because gallbladder heat invades the stomach and disrupts its downbearing, pinellia and fresh ginger harmonize the stomach and stop retching as assistants (ginger also restraining pinellia's toxicity); because the pathogen entered shaoyang on a background of deficiency, ginseng, jujube, and honey-fried licorice supplement qi and fortify the spleen, supporting the upright to expel the pathogen. The Qing physician Xu Lingtai's remark that 'the marvel of this formula lies in the ginseng' highlights how central supporting the upright is to 'harmonizing.' Cold and warm together, draining and tonifying together — hence its capacity to 'harmonize' disharmony between exterior and interior, organ and organ.

Pattern, not disease: 'half-exterior, half-interior' and the shaoyang pivot

The textbook mechanism is 'pathogen invading shaoyang, the pivot impaired.' Shaoyang lies between the taiyang exterior and yangming interior; when the pathogen lodges there, upright and pathogen contend — when the upright prevails and pushes outward there is fever, when the pathogen prevails and moves inward there is chill, hence the alternation. The shaoyang channel traverses the chest and flanks, so impaired channel qi rising as heat produces fullness, irritability, a bitter taste, dry throat, and dizziness; gallbladder heat invading the stomach produces the reluctance to eat and the retching. Because the pathogen is neither at the exterior (so not for sweating) nor in the interior (so not for purging or vomiting) but 'half-and-half,' only the harmonizing method fits.

'Shaoyang,' 'pivot,' and 'half-exterior half-interior' are traditional functional constructs, not synonyms for modern anatomy or microbiology. The tradition distinguishes a narrow sense (pathogen in the shaoyang half-and-half) from a broad one: as the textbook definition of the 'harmonizing method' allows, pathogen in shaoyang, liver-spleen disharmony, mixed cold and heat, and simultaneous exterior-interior disease may all be considered. Precisely because the broad use is so wide, the prerequisite of pattern differentiation matters all the more — similar symptoms do not imply the same pattern, and 'a single sign is enough' is a professional's judgment within a grasp of the whole mechanism, never a license to match formula to symptom.

A lineage, not a single formula: historical development of the bupleurum formulas

The formula's stature comes from the large bupleurum-formula system it generated. Zhongjing himself modified it: removing ginseng and licorice and adding rhubarb, bitter orange, and peony yields Da Chaihu (Major Bupleurum) Decoction, shifting from 'harmonizing primarily' to 'harmonizing plus purging' for a combined shaoyang-yangming pattern with alternating fever, epigastric fullness and pain, vomiting, and constipation. Others — Chaihu Guizhi Decoction (with Guizhi Decoction, for shaoyang plus a taiyang exterior), Chaihu Jia Longgu Muli Decoction, and Chaihu Guizhi Ganjiang Decoction — all build on the bupleurum-scutellaria core. Later liver-coursing formulas such as Sini San and Xiaoyao San also trace their descent to this line.

Commentators analyzed its logic deeply — Ke Qin and You Zaijing on the meaning of 'harmonizing,' Xu Lingtai on the centrality of ginseng. Japanese Kampo medicine elevated it to a principal formula, using 'Sho-saiko-to (TJ-9)' widely for chronic liver disease. Modern classical-formula physicians describe it as 'an ancient antipyretic and anti-inflammatory' and a common formula for the protracted phase of febrile illness. This diffusion — from Han-dynasty China across East Asia to the present — is also the backdrop for the safety discussion below: under one formula name, different preparations, populations, and co-medications can present sharply different risk pictures.

Active constituents: saikosaponins, baicalin, and their double edge

The most-studied actives are bupleurum's saikosaponins (A, B, C, D) and scutellaria's baicalin and baicalein. Liver-disease reviews report that saikosaponins and scutellaria flavonoids show antioxidant, cytoprotective, and antifibrotic activity in vitro and in several animal models, with baicalin and baicalein chemically resembling silybinin. A HepG2 2.2.15 cell study (PMID 17436373) found that the formula inhibited hepatitis B virus replication and HBeAg expression (p<0.0001), while the authors noted its saikosaponin content is very low, so the antiviral activity may not be saikosaponin-mediated — a reminder of how complex the constituent-activity relationship is.

Yet saikosaponins cut both ways. The literature notes a lack of systematic pharmacokinetic study, inconsistent doses across studies, contradictory experimental evidence, and a risk of hepatotoxicity on overdose — a modern footnote to 'benefit and toxicity share one source.' Scutellaria constituents have also historically drawn hepatotoxicity attention. So the modern pharmacology is no endorsement of 'natural equals safe'; on the contrary, it shows that the dose, preparation, and population of the actives determine the balance of benefit and risk.

Evidence, and a safety history that must be told: the TJ-9 interstitial-pneumonia episode

This formula is the clearest case for checking formula, preparation, and population separately. In the 1990s Japan used the Kampo preparation TJ-9 widely in chronic hepatitis-C and other patients, and a cluster of drug-induced interstitial-pneumonia cases followed. The literature describes roughly 66 Japanese patients — largely a chronic-hepatitis population — developing interstitial pneumonia during TJ-9 use; the proposed mechanism involves TJ-9 inducing excessive production of G-CSF, and because interferon itself can induce interstitial pneumonia, combining the two may compound the risk. Accordingly, from 1994 Japan listed 'co-use with interferon' as a contraindication, and in 1996 the Japanese Ministry of Health issued a formal interstitial-pneumonia warning. Thrombocytopenic purpura and induction of autoimmune hepatitis have also been reported.

Notably, Chinese authors have observed that Chinese-language literature rarely reports interstitial pneumonia or drug-induced liver injury from this decoction — a geographic divergence that itself points to preparation form (granule versus decoction), population (chronic hepatitis, interferon-treated), co-medication, and long-term use as the key variables. As for efficacy, most work is in-vitro, animal, and preliminary clinical observation, lacking large high-quality RCTs and often mixing preparations and co-therapy. The defensible statement is that mechanistic and preliminary clinical research exists alongside clear preparation-related safety signals — not that the formula is proven to treat hepatitis and is safe.

Quality standards, patent medicines, and the Western-drug context

Bupleurum, scutellaria, pinellia, ginseng, and licorice are all Chinese Pharmacopoeia materials with their own identity and assay markers (scutellaria by baicalin, bupleurum by saikosaponins among others). The market offers several forms — decoction, granule, the patent 'Xiao Chaihu Granules' — plus Japan's TJ-9; but same-named or similarly named products differ markedly in botanical source, ratio, extraction, and dose and are not interchangeable, which is exactly the lesson of the TJ-9 history.

As contextual overlap (relationship only, not an efficacy comparison): modern research on this formula is repeatedly tied to interferon, a class of antiviral/immunomodulatory drugs — because both can be associated with interstitial pneumonia, their 'co-use contraindication' became a textbook case of herb-drug interaction. Scutellaria constituents such as baicalin may also affect certain drug-metabolizing enzymes, and ginseng and licorice each carry reported interactions with hypoglycemic, antihypertensive, anticoagulant, and corticosteroid drugs. This traditional-Western intersection is precisely why the formula requires professional coordination rather than self-layering.

Safety boundaries and contraindications

On the modern safety data, this formula — especially its preparations — carries clear risk signals in specific populations: co-use with interferon may raise interstitial-pneumonia risk (a contraindication in Japan), and chronic-liver-disease, interferon-treated, and long-term users warrant particular vigilance for pulmonary and hepatic adverse effects. Pinellia requires proper processing (raw pinellia is toxic); ginseng and licorice may interact with hypoglycemic, antihypertensive, diuretic, cardiac, and corticosteroid drugs, and licorice constituents can affect blood pressure and electrolytes with prolonged or high-dose use. Pregnancy, childhood, liver disease, and polypharmacy all require professional pattern differentiation and pharmacist review.

On the boundary of use: fever and liver disease require modern work-up of cause first, and persistent fever, cough and breathlessness, dyspnea, jaundice, or abnormal liver function call for prompt medical care rather than self-treatment. The formula is an excellent model for the wisdom of the harmonizing method and for 'preparation safety,' but its clinical use belongs to professional pattern differentiation and pharmacist review.

A checklist for reading any formula article

1. Formula, preparation, population: does a stated effect or risk come from the canonical decoction, Xiao Chaihu Granules, or Japan's TJ-9 — and in which population (e.g. chronic hepatitis, interferon-treated)? These must not be conflated.
2. Pattern versus disease: has 'shaoyang pattern' been swapped for hepatitis, a cold, or another modern diagnosis?
3. Evidence tier: does the conclusion rest on in-vitro/animal/preliminary observation, or high-quality human RCTs?
4. Safety and interactions: are the interstitial-pneumonia risk with interferon, the hepatotoxicity signal, and pinellia processing addressed?
5. Dose and procedure: responsible education identifies the entity and stops short of individual dosing, decoction methods, and modifications — prescriptions require a qualified physician and pharmacist.

Educational and academic reference only. It does not provide a diagnosis, prescription, dosage, or treatment recommendation. Preparations of this formula carry clear safety warnings in specific populations (such as co-use with interferon); seek qualified care for persistent or worsening symptoms or for dyspnea or jaundice, and consult a licensed physician and pharmacist for any prescription.